You are here

Home / Our Funding / Where our funding goes / Institutions we've funded / University of California, Los Angeles
  • Share
  • Print

University of California, Los Angeles

Total Awards: 
60
ICOC Committed funds: 
188 470 196

Awards to the Institution

Funding
New Faculty I: Kathrin Plath In vitro reprogramming of mouse and human somatic cells to an embryonic state $2,229,427
New Faculty I: Siavash Kurdistani Epigenetics in cancer stem cell initiation and clinical outcome prediction $3,238,450
New Faculty I: Hanna Mikkola Mechanisms of Hematopoietic stem cell Specification and Self-Renewal $2,286,900
Shared Labs: Owen Witte CIRM Shared Research Laboratories $3,740,497
Comprehensive Grant: Gay Crooks Regulated Expansion of Lympho-hematopoietic Stem and Progenitor Cells from Human Embryonic Stem Cells (hESC) $2,551,088
Comprehensive Grant: Zack Jerome Human Embryonic Stem Cell Therapeutic Strategies to Target HIV Disease $2,516,831
Comprehensive Grant: Guoping Fan Epigenetic gene regulation during the differentiation of human embryonic stem cells: Impact on neural repair $2,516,613
SEED Grant: Zoran Galic Genetic Enhancement of the Immune Response to Melanoma via hESC-derived T cells $642,501
SEED Grant: Hanna Mikkola Improving microenvironments to promote hematopoietic stem cell development from human embryonic stem cells $577,037
SEED Grant: Michael Teitell Role of Mitochondria in Self-Renewal Versus Differentiation of Human Embryonic Stem Cells $635,024
SEED Grant: William Lowry Modeling Human Embryonic Development with Human Embryonic Stem Cells $571,575
SEED Grant: Irvin Chen Genetic modification of the human genome to resist HIV-1 infection and/or disease progression $642,652
SEED Grant: Siavash Kurdistani Cellular epigenetic diversity as a blueprint for defining the identity and functional potential of human embryonic stem cells $641,047
SEED Grant: Noriyuki Kasahara Down-Regulation of Alloreactive Immune Responses to hES Cell-Derived Graft Tissues $469,219
Traning Grant I-2: Donald Kohn Training Grant 1 $2,390,826
Disease Team Therapy Planning I: Antoni Ribas Genetic Re-programming of Stem Cells to Fight Cancer $110,000
Disease Team Therapy Planning I: Stanley Nelson Combination therapy to Enhance Antisense Mediated Exon Skipping for Duchenne Muscular Dystrophy $86,414
Early Translational I: Gabriel Travis Development of a Stem Cell-based Transplantation Strategy for Treating Age-related Macular Degeneration $5,503,069
Transplantation Immunology: Gay Crooks Engineering Thymic Regeneration to Induce Tolerance $1,357,398
Disease Team Therapy Development - Research: Stanley Nelson Combination Therapy to Enhance Antisense Mediated Exon Skipping for Duchenne Muscular Dystrophy $6,000,000
Disease Team Therapy Development - Research: Antoni Ribas Genetic Re-programming of Stem Cells to Fight Cancer $19,999,563
Basic Biology IV: Kathrin Plath Understanding the status of the X chromosomes in human ESCs and preimplantation embryos $1,382,400
Basic Biology IV: Owen Witte Trop2 dependent and independent mechanisms of self-renewal in human cancer stem cells $1,382,400
New Faculty Physician Scientist: Reza Ardehali Preclinical evaluation of human embryonic stem cell-derived cardiovascular progenitors $2,930,388
New Faculty Physician Scientist: Ali Nsair Human Induced Pluripotent Stem Cell-Derived Cardiovascular Progenitor Cells for Cardiac Cell Therapy. $3,004,315
Tissue Collection for Disease Modeling: Brigitte Gomperts Using human induced pluripotent stem cells to improve our understanding of Idiopathic Pulmonary Fibrosis $934,515
Traning Grant I-1: Owen Witte CIRM Type I Comprehensive Training Program $3,750,000
Early Translational from Disease Team Conversion: Irvin Chen HPSC based therapy for HIV disease using RNAi to CCR5. $1,505,000
Major Facilities: Gene Block No Title $19,854,900
Disease Team Planning: Irvin Chen Stem Cell Therapy for AIDS- Disease Team Planning $52,500
Total:
$93,502,549.00

Pages

Icon for xls export

© 2013 California Institute for Regenerative Medicine